This draft guidance is being submitted for comment purposes only.

 

You should submit comments and suggestions regarding this draft document within 90 days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. Alternatively, electronic comments may be submitted to www.regulations.gov. Identify all comments with the docket number listed in the notice of availability that publishes in the Federal Register.